U.S. Semiconductors Stock News

Keel Infrastructure stock reacts to Sherbrooke data center and capacity shift Keel Infrastructure (KEEL) is in focus after securing Sherbrooke approval to consolidate 96 MW of existing Bitcoin mining capacity into a single campus and recategorize it for high performance computing and AI workloads. The agreement with Hydro Sherbrooke, along with a land purchase plan east of Montréal, gives Keel Infrastructure a defined path toward an HPC and AI oriented data center project, subject to...

BGM Group (BGM) has reported FY 2025 first half revenue of about US$14.3 million and a basic EPS loss of US$0.03 per share, setting a mixed tone for investors watching the company’s momentum against a higher revenue base. The company has seen revenue move from roughly US$12.6 million in the first half of FY 2024 to US$14.3 million in the first half of FY 2025, while basic EPS shifted from a profit of US$0.06 to a loss of US$0.03. This puts the spotlight firmly on how much of that top line is...

AI is reshaping work, and not just in tech. As automation spreads and job postings in exposed industries come under pressure, demand for reskilling, upskilling, and smarter human capital management is in sharper focus. That is the core idea behind this Workforce Reskilling and Human Capital Development screener. It looks at companies tied directly to training, staffing, and credentialing that could stand to gain as employers and workers adapt. In this article, you will see 3 stocks that...

Monarch Casino & Resort (MCRI) has put up another solid quarter, with Q2 2026 revenue of US$142.6 million and basic EPS of US$1.82, while trailing twelve month EPS sits at US$6.37 on revenue of US$562.0 million. The company has seen quarterly revenue move between US$125.4 million and US$142.8 million since early 2025, with basic EPS ranging from US$1.08 to US$1.82 over the same stretch. This sets up a story where earnings growth of 45.7% and a net profit margin of 20.4% over the past year...

Wave Life Sciences (WVE) has attracted investor attention after recent share price swings, with the stock closing at US$5.79. The move comes against a backdrop of mixed short term and longer term returns. See our latest analysis for Wave Life Sciences. Recent trading puts Wave Life Sciences on a weak near term trend, with the 7 day share price return down 5.55% and the 90 day share price return down 21.54%. However, the 3 year total shareholder return of 48.08% shows a much stronger longer...

Tariffs on imported generic drugs of up to 200% from 2029 could reshape where and how the medicines in US pharmacies are made, and that has real implications for US-based generic drug stocks. With 90% of US prescriptions filled by generics and about 70% of those sourced from overseas, investors are right to pay attention as policy pressure builds for more domestic manufacturing. This article looks at how that policy shock could affect US-based generic manufacturers and highlights three stocks...

Expro stock has delivered a strong 88.2% return over the past year, yet the current valuation checks point to a company that screens as expensive rather than a clear bargain. The 88.2% one year gain puts Expro firmly in the spotlight and raises the question of how much of the good news is already reflected in the share price. Expectations around Expro's ability to convert its project pipeline into steady cash flows can support the current valuation. However, any setback in execution or...

OFG Bancorp (OFG) has put up another solid set of numbers for Q2 2026, with total revenue of US$177.3 million and basic EPS of US$1.39, backed by trailing twelve month revenue of US$651.2 million and EPS of US$5.09 that sit against a 13.2% earnings growth rate over the past year. Over the last few quarters, revenue has moved from US$160.7 million in Q2 2025 to US$152.4 million in Q4 2025, US$163.5 million in Q1 2026 and now US$177.3 million in Q2 2026. Quarterly EPS has tracked from US$1.15...

Medline stock has gained 8.8% over the past month, and while the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, the broader valuation checks paint a more mixed picture rather than a clear bargain. An 8.8% return over the past month suggests sentiment around Medline has turned more positive in the short term. The planned 1,000,000 square foot distribution facility in Perris, California can support expectations for future cash flow, but the capital intensity...

Southern First Bancshares (SFST) reported Q2 2026 total revenue of US$34.9 million and basic EPS of US$1.22, with trailing 12 month revenue at US$128.8 million and EPS at US$4.73, alongside trailing year earnings growth of 81.2%. Over recent quarters, the company has seen quarterly revenue move from US$27.9 million and EPS of US$0.81 in Q2 2025 to US$34.9 million and EPS of US$1.22 in Q2 2026. At the same time, trailing 12 month revenue shifted from US$102.9 million and EPS of US$2.71 to...

TechnipFMC's share price has very large 5 year returns behind it and now sits at US$74.62. A Discounted Cash Flow (DCF) intrinsic value estimate points to roughly 30.7% upside, while market multiples lean the other way and the broader value checks flag the stock as far from a clear bargain. Over 5 years, TechnipFMC has delivered very large total returns. This puts extra focus on whether the current price is still supported by fundamentals. Future project execution and cash flow visibility...

Mobileye Global (NasdaqGS:MBLY) agreed to supply Stellantis with cloud-enhanced advanced driver-assistance systems starting in 2027. The partnership focuses on software-driven, connected safety features that rely on data and updates from the cloud. The deal expands Mobileye's role as a core technology provider to large global automakers. Mobileye Global, which trades at $8.99, is drawing fresh attention with its new agreement to power Stellantis vehicles with cloud-based driver-assistance...

Zions Bancorporation National Association (ZION) has put up a big second quarter, with Q2 2026 revenue at US$1.1 billion and basic EPS of US$3.09 on net income of US$452 million anchoring the latest set of results. The company has seen revenue move from US$839 million and EPS of US$1.64 in Q2 2025 to US$1.1 billion and EPS of US$3.09 in Q2 2026, alongside trailing twelve month revenue of US$3.7 billion and EPS of US$7.88. This sets up a report where profitability and margins are firmly in...

DNOW stock has returned 47.5% over the past five years, and with the latest checks still framing it as undervalued, investors are weighing whether the current US$14.25 share price fully reflects what the business is worth. Over five years, DNOW has delivered a 47.5% total return, which points to steady value creation for shareholders over a longer holding period. Future valuation may hinge on how consistently DNOW can convert its operations into cash flow, while any sustained pressure on...

Synchrony Financial (SYF) opened Q2 2026 with total revenue of US$2,517 million and basic EPS of US$2.63, supported by trailing twelve month revenue of US$9.9 billion and EPS of US$10.19 that have tracked alongside a 7.2% rise in earnings over the past year and a trailing net margin of 34.7%. Over recent quarters the company has seen revenue move between US$2,227 million and US$2,677 million and quarterly EPS range from US$1.91 to US$2.89, setting up this latest print as part of a broader...

First United (FUNC) has just posted Q2 2026 results with revenue of US$23.2 million and basic EPS of US$0.88, setting the tone for how investors read the latest quarter. The company has seen revenue move from US$20.9 million and EPS of US$0.92 in Q2 2025 to US$23.2 million and EPS of US$0.88 in Q2 2026, while trailing 12 month figures stand at US$90.4 million of revenue and EPS of US$3.87. With net income at US$5.7 million for the quarter, the focus now is on how sustainably First United is...

Maravai LifeSciences’ subsidiary TriLink BioTechnologies recently received a patent from the China National Intellectual Property Administration covering its methods for synthesizing RNA molecules, including the full suite of CleanCap® capping analogs and the latest M6 analog. This patent broadens protection for CleanCap® in a major mRNA therapeutics and vaccine market, potentially reinforcing Maravai’s competitive moat in nucleic acid tools. We’ll now examine how this strengthened China...

Peoples Bancorp of North Carolina (PEBK) just posted Q2 2026 results with total revenue of US$22.8 million and basic EPS of US$0.98, set against a trailing twelve month EPS of US$3.76 and net income of US$20.0 million. The company has seen revenue range from US$20.2 million to US$24.6 million per quarter over the past six reported periods, with quarterly EPS moving between US$0.70 and US$1.25. Reported earnings growth of 17.2% over the last year may frame how investors interpret this update...

Chubb (NYSE:CB) is reshaping leadership at its global reinsurance unit, Chubb Tempest Re. James Wixtead has been appointed Executive Chairman and Michael O'Donnell President of Chubb Tempest Re. These leadership changes are set to take effect on August 1, 2026. For investors following Chubb, the reinsurance arm is a core part of how the company manages large and complex risk exposures. Reinsurance has been a key focus across the insurance sector, as companies adjust structures, pricing, and...

KeyCorp (KEY) has just posted Q2 2026 results with total revenue of US$1,864 million and basic EPS of US$0.47, while trailing twelve month revenue stands at US$7,371 million and EPS at US$1.73 as the company moves on from a period that previously included losses. Over the past year, revenue has shifted from US$4,463 million on a trailing basis with EPS at a loss of US$0.12 to the latest trailing totals of US$7,371 million and EPS of US$1.73, marking a very large rebound in earnings with net...

BOK Financial (BOKF) opened Q2 2026 with US$589.4 million in revenue and basic EPS of US$2.94, while trailing twelve month revenue stood at US$2.3 billion and EPS at US$10.60, giving investors a clear read on both the latest quarter and the broader earnings run rate. Over recent quarters the company has seen revenue move from US$536.2 million and EPS of US$2.19 in Q2 2025 to US$589.4 million and EPS of US$2.94 in Q2 2026. This sets up this release as a check on how efficiently those revenues...

ServisFirst Bancshares (SFBS) has just posted its Q2 2026 numbers, with total revenue at US$157.1 million and basic EPS of US$1.57, alongside trailing twelve month revenue of US$585.2 million and EPS of US$5.87 that reflect the company’s recent earnings momentum. Over the past year, ServisFirst Bancshares has seen revenue climb from US$477.1 million to US$585.2 million and EPS move from US$4.41 to US$5.87 on a trailing twelve month basis, setting a clear earnings benchmark for this quarter’s...

Halliburton (HAL) has put fresh numbers on the board for Q2 2026, reporting revenue of US$5,714 million and basic EPS of US$0.64, alongside net income of US$534 million, with trailing twelve month EPS at US$1.91 on revenue of US$22.4 billion. The company has seen quarterly revenue move from US$5,510 million in Q2 2025 to US$5,657 million in Q4 2025 and US$5,714 million in Q2 2026. Basic EPS shifted from US$0.55 to US$0.70 and then to US$0.64 across those same quarters, which may prompt...

With inflation, energy costs and interest rates all pulling markets in different directions, many investors are looking for opportunities where current prices do not fully reflect a company’s cash flow potential. That is exactly what the Undervalued Stocks Based On Cash Flows screener aims to highlight, using SWS DCF valuation to flag companies that trade below an estimate of their fair value. In this article, you will see 3 stocks from this screener that may interest value oriented investors...